KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

New York Times (NYT) Cash & Equivalents (2016 - 2025)

New York Times (NYT) has disclosed Cash & Equivalents for 17 consecutive years, with $255.4 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 28.08% to $255.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $255.4 million through Dec 2025, up 28.08% year-over-year, with the annual reading at $255.4 million for FY2025, 28.08% up from the prior year.
  • Cash & Equivalents hit $255.4 million in Q4 2025 for New York Times, up from $249.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $324.0 million in Q3 2021 to a low of $161.3 million in Q2 2022.
  • Historically, Cash & Equivalents has averaged $235.4 million across 5 years, with a median of $229.1 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: crashed 49.72% in 2022 and later skyrocketed 52.24% in 2023.
  • Year by year, Cash & Equivalents stood at $320.0 million in 2021, then plummeted by 30.81% to $221.4 million in 2022, then soared by 30.76% to $289.5 million in 2023, then tumbled by 31.1% to $199.4 million in 2024, then increased by 28.08% to $255.4 million in 2025.
  • Business Quant data shows Cash & Equivalents for NYT at $255.4 million in Q4 2025, $249.3 million in Q3 2025, and $198.2 million in Q2 2025.